Recombinant domain IV of perlecan binds to nidogens, laminin–nidogen complex, fibronectin, fibulin‐2 and heparin
Domain IV of mouse perlecan, which consists of 14 immunoglobulin superfamily (IG) modules, was prepared from recombinant human cell culture medium in the form of two fragments, IV‐1 (IG2–9, 100 kDa) and IV‐2 (IG10–15, 66 kDa). Both fragments bound to a heparin column, being eluted at ionic strengths...
Saved in:
Published in | European journal of biochemistry Vol. 259; no. 3; pp. 917 - 926 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Science Ltd
01.02.1999
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Domain IV of mouse perlecan, which consists of 14 immunoglobulin superfamily (IG) modules, was prepared from recombinant human cell culture medium in the form of two fragments, IV‐1 (IG2–9, 100 kDa) and IV‐2 (IG10–15, 66 kDa). Both fragments bound to a heparin column, being eluted at ionic strengths either below (IV‐2) or above (IV‐1) physiological level, and could thus be readily purified. Electron microscopy demonstrated an elongated shape (20–25 nm), and folding into a native structure was indicated by immunological assay and CD spectroscopy. Solid‐phase and surface plasmon resonance assays demonstrated strong binding of fragment IV‐1 to fibronectin, nidogen‐1, nidogen‐2 and the laminin‐1–nidogen‐1 complex, with Kd values in the range 4–17 n
m. The latter binding apparently occurs through nidogen‐1, as shown by the formation of ternary complexes. Only moderate binding was observed for fibulin‐2 and collagen IV and none for fibulin‐1 and BM‐40. Fragment IV‐2 showed a more restricted pattern of binding, with only weaker binding to fibronectin and fibulin‐2. None of these activities could be demonstrated for recombinant fragments corresponding to the N‐terminal perlecan domains I to III. This indicates a special role for domain IV in the integration of perlecan into basement membranes and other extracellular structures via protein–protein interactions. |
---|---|
AbstractList | Domain IV of mouse perlecan, which consists of 14 immunoglobulin superfamily (IG) modules, was prepared from recombinant human cell culture medium in the form of two fragments, IV‐1 (IG2–9, 100 kDa) and IV‐2 (IG10–15, 66 kDa). Both fragments bound to a heparin column, being eluted at ionic strengths either below (IV‐2) or above (IV‐1) physiological level, and could thus be readily purified. Electron microscopy demonstrated an elongated shape (20–25 nm), and folding into a native structure was indicated by immunological assay and CD spectroscopy. Solid‐phase and surface plasmon resonance assays demonstrated strong binding of fragment IV‐1 to fibronectin, nidogen‐1, nidogen‐2 and the laminin‐1–nidogen‐1 complex, with Kd values in the range 4–17 n
m. The latter binding apparently occurs through nidogen‐1, as shown by the formation of ternary complexes. Only moderate binding was observed for fibulin‐2 and collagen IV and none for fibulin‐1 and BM‐40. Fragment IV‐2 showed a more restricted pattern of binding, with only weaker binding to fibronectin and fibulin‐2. None of these activities could be demonstrated for recombinant fragments corresponding to the N‐terminal perlecan domains I to III. This indicates a special role for domain IV in the integration of perlecan into basement membranes and other extracellular structures via protein–protein interactions. Domain IV of mouse perlecan, which consists of 14 immunoglobulin superfamily (IG) modules, was prepared from recombinant human cell culture medium in the form of two fragments, IV-1 (IG2-9, 100 kDa) and IV-2 (IG10-15, 66 kDa). Both fragments bound to a heparin column, being eluted at ionic strengths either below (IV-2) or above (IV-1) physiological level, and could thus be readily purified. Electron microscopy demonstrated an elongated shape (20-25 nm), and folding into a native structure was indicated by immunological assay and CD spectroscopy. Solid-phase and surface plasmon resonance assays demonstrated strong binding of fragment IV-1 to fibronectin, nidogen-1, nidogen-2 and the laminin-1-nidogen-1 complex, with Kd values in the range 4-17 nM. The latter binding apparently occurs through nidogen-1, as shown by the formation of ternary complexes. Only moderate binding was observed for fibulin-2 and collagen IV and none for fibulin-1 and BM-40. Fragment IV-2 showed a more restricted pattern of binding, with only weaker binding to fibronectin and fibulin-2. None of these activities could be demonstrated for recombinant fragments corresponding to the N-terminal perlecan domains I to III. This indicates a special role for domain IV in the integration of perlecan into basement membranes and other extracellular structures via protein-protein interactions. Domain IV of mouse perlecan, which consists of 14 immunoglobulin superfamily (IG) modules, was prepared from recombinant human cell culture medium in the form of two fragments, IV‐1 (IG2–9, 100 kDa) and IV‐2 (IG10–15, 66 kDa). Both fragments bound to a heparin column, being eluted at ionic strengths either below (IV‐2) or above (IV‐1) physiological level, and could thus be readily purified. Electron microscopy demonstrated an elongated shape (20–25 nm), and folding into a native structure was indicated by immunological assay and CD spectroscopy. Solid‐phase and surface plasmon resonance assays demonstrated strong binding of fragment IV‐1 to fibronectin, nidogen‐1, nidogen‐2 and the laminin‐1–nidogen‐1 complex, with K d values in the range 4–17 n m . The latter binding apparently occurs through nidogen‐1, as shown by the formation of ternary complexes. Only moderate binding was observed for fibulin‐2 and collagen IV and none for fibulin‐1 and BM‐40. Fragment IV‐2 showed a more restricted pattern of binding, with only weaker binding to fibronectin and fibulin‐2. None of these activities could be demonstrated for recombinant fragments corresponding to the N‐terminal perlecan domains I to III. This indicates a special role for domain IV in the integration of perlecan into basement membranes and other extracellular structures via protein–protein interactions. |
Author | Yamada, Yoshihiko Göhring, Walter Kohfeldt, Eddie Timpl, Rupert Hopf , Michael |
Author_xml | – sequence: 1 givenname: Michael surname: Hopf fullname: Hopf , Michael – sequence: 2 givenname: Walter surname: Göhring fullname: Göhring, Walter – sequence: 3 givenname: Eddie surname: Kohfeldt fullname: Kohfeldt, Eddie – sequence: 4 givenname: Yoshihiko surname: Yamada fullname: Yamada, Yoshihiko – sequence: 5 givenname: Rupert surname: Timpl fullname: Timpl, Rupert |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/10092882$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkMtO3DAUhi0EguHyCsirrkjqW2J70UU7Gi4SElJb2FpO7IBHiZ3GGTHseAQk3rBPgkNm0WVX5_af_9jfMdj3wVsAIEY5Rqz8us4xoyTDlPAcSylzhHBKt3tgMQ8QpftgkbosI7Ioj8BxjGuEUClLfgiOMEKSCEEWYPxp69BVzms_QhM67Ty8eYChgb0dWltrD9PQRDgG6J0Jj9bHC9jqznnn_76-73owmfSt3V7AxlVDemw9Ov9ZbNpJ90ag9gY-2V4Pzp-Cg0a30Z7t4gm4v1z9Xl5nt3dXN8vvt1nNBOaZqLQQopFEY8IIx5SyutCGY1vJmjNcsAZTZgizSKMi_awUsqBccFOZknFGT8CX2bcfwp-NjaPqXKxt22pvwyaqRIOVEoskFLOwHkKMg21UP7hODy8KIzURV2s1gVUTcTURV5_E1Tatnu9ubKrOmn8WZ8RJ8G0WPLvWvvy3sbpc_fiVMvoBmReSmg |
CitedBy_id | crossref_primary_10_1074_jbc_M011493200 crossref_primary_10_1074_jbc_M513746200 crossref_primary_10_1016_j_matbio_2018_01_012 crossref_primary_10_4244_EIJV6I1A20 crossref_primary_10_1007_s10585_015_9720_7 crossref_primary_10_1016_j_pharmthera_2012_02_002 crossref_primary_10_1016_j_job_2012_12_004 crossref_primary_10_1007_s00441_009_0866_y crossref_primary_10_1002_path_3020 crossref_primary_10_1016_j_tvjl_2005_02_008 crossref_primary_10_1128_jvi_00480_23 crossref_primary_10_1002_jemt_20562 crossref_primary_10_1007_s00441_009_0853_3 crossref_primary_10_1016_j_matbio_2013_08_004 crossref_primary_10_1002_anbr_202000068 crossref_primary_10_1007_s10911_020_09447_2 crossref_primary_10_1242_jcs_226860 crossref_primary_10_1006_excr_2002_5611 crossref_primary_10_1038_sj_eye_6700199 crossref_primary_10_1128_MCB_25_15_6846_6856_2005 crossref_primary_10_1242_dev_129_11_2711 crossref_primary_10_1071_CH05145 crossref_primary_10_1074_jbc_M210529200 crossref_primary_10_1016_j_progpolymsci_2015_02_004 crossref_primary_10_1016_j_exer_2008_08_002 crossref_primary_10_1002_bdrc_20003 crossref_primary_10_1002_jemt_20567 crossref_primary_10_1038_nrc1094 crossref_primary_10_1042_BCJ20180695 crossref_primary_10_1165_rcmb_2021_0091TR crossref_primary_10_1016_S0012_1606_03_00014_9 crossref_primary_10_1242_dev_158881 crossref_primary_10_1083_jcb_147_5_1109 crossref_primary_10_4161_cam_22680 crossref_primary_10_1006_jmbi_2001_4878 crossref_primary_10_4161_cam_23411 crossref_primary_10_1002_humu_20388 crossref_primary_10_1046_j_0014_2956_2001_02437_x crossref_primary_10_1074_mcp_RA120_001998 crossref_primary_10_1002_dvdy_22129 crossref_primary_10_1074_jbc_M111826200 crossref_primary_10_1177_002215540004801001 crossref_primary_10_1016_S0014_5793_99_01362_9 crossref_primary_10_3390_ijms21020679 crossref_primary_10_1086_340390 crossref_primary_10_1016_j_matbio_2012_02_006 crossref_primary_10_1006_bbrc_1999_1714 crossref_primary_10_1074_jbc_M109_025148 crossref_primary_10_1016_j_ydbio_2005_02_036 crossref_primary_10_18632_aging_202789 crossref_primary_10_1002_adtp_201900034 crossref_primary_10_1007_s00586_008_0712_z crossref_primary_10_1046_j_1432_1327_2000_01337_x crossref_primary_10_1038_nrm1702 crossref_primary_10_1016_j_matbio_2016_09_003 crossref_primary_10_3390_genes9110556 crossref_primary_10_1177_0271678X17722436 crossref_primary_10_3389_fonc_2019_00796 crossref_primary_10_1242_jcs_041095 crossref_primary_10_1016_j_jbc_2024_107429 crossref_primary_10_1089_ten_teb_2008_0329 crossref_primary_10_1172_JCI90854 crossref_primary_10_1074_jbc_M114_562157 crossref_primary_10_1002_1099_1352_200011_12_13_6_388__AID_JMR516_3_0_CO_2 crossref_primary_10_1016_j_matbio_2018_07_004 crossref_primary_10_1038_s41392_021_00512_8 crossref_primary_10_1371_journal_pone_0269037 crossref_primary_10_1080_07357900701513272 crossref_primary_10_3390_ijms221910430 crossref_primary_10_1186_1471_213X_7_29 crossref_primary_10_3928_1081597X_20211007_02 crossref_primary_10_1074_jbc_M110_188615 crossref_primary_10_1161_01_RES_0000026056_81424_DA crossref_primary_10_18632_oncotarget_14627 crossref_primary_10_1093_jb_mvy008 crossref_primary_10_1016_j_matbio_2003_10_006 crossref_primary_10_1007_s00125_017_4524_8 crossref_primary_10_1016_j_lfs_2022_121190 crossref_primary_10_1177_154405910608500203 crossref_primary_10_1074_jbc_M409882200 crossref_primary_10_1021_bi050245u crossref_primary_10_1002_bdrc_10006 crossref_primary_10_1016_j_matbio_2012_05_002 crossref_primary_10_4049_jimmunol_176_5_3196 crossref_primary_10_1016_j_matbio_2007_09_007 crossref_primary_10_1016_j_ajpath_2011_05_024 crossref_primary_10_1016_S0945_053X_02_00070_7 crossref_primary_10_1074_jbc_M312694200 crossref_primary_10_1016_j_actbio_2021_08_032 crossref_primary_10_1002_bdrc_20172 crossref_primary_10_1074_jbc_M108285200 crossref_primary_10_1016_j_matbio_2014_04_005 crossref_primary_10_3389_fcell_2022_1056523 crossref_primary_10_1002_bies_20748 crossref_primary_10_1007_s10237_021_01521_w crossref_primary_10_1074_mcp_RA119_001654 crossref_primary_10_1002_dvdy_20425 crossref_primary_10_1038_82638 crossref_primary_10_1111_febs_12197 crossref_primary_10_1006_jmbi_1999_3259 crossref_primary_10_1002_dvdy_21593 crossref_primary_10_1021_pr070032m crossref_primary_10_1016_j_exer_2020_108325 crossref_primary_10_1006_exer_2000_0952 crossref_primary_10_1016_j_actbio_2016_09_043 crossref_primary_10_1111_j_1582_4934_2007_00031_x crossref_primary_10_1359_jbmr_2002_17_1_48 crossref_primary_10_3389_fcell_2022_856261 crossref_primary_10_1126_science_288_5463_150 crossref_primary_10_1074_jbc_275_10_7095 crossref_primary_10_1096_fasebj_13_13_1743 crossref_primary_10_1016_j_ydbio_2018_06_014 |
Cites_doi | 10.1002/j.1460-2075.1993.tb05836.x 10.1016/S0021-9258(17)39569-8 10.1111/j.1432-1033.1988.tb14430.x 10.1242/dev.124.3.683 10.1074/jbc.271.17.10079 10.1242/dev.120.7.2003 10.1016/S0021-9258(18)45431-2 10.1111/j.1432-1033.1991.tb16214.x 10.1093/emboj/17.2.335 10.1042/bj3260829 10.1111/j.1432-1033.1995.0551d.x 10.1083/jcb.119.4.945 10.1046/j.1432-1327.1998.2550060.x 10.1002/j.1460-2075.1996.tb00899.x 10.1111/j.1432-1033.1989.tb15013.x 10.1016/S0945-053X(96)90138-9 10.1006/abbi.1995.1345 10.1074/jbc.271.16.9595 10.1074/jbc.270.1.404 10.1111/j.1432-1033.1997.t01-1-00115.x 10.1111/j.1432-1033.1996.00827.x 10.1006/jmbi.1996.0191 10.1002/j.1460-2075.1992.tb05527.x 10.1042/bj3020625 10.1016/0959-440X(93)90147-D 10.1083/jcb.116.2.559 10.1016/S0022-2836(84)71582-8 10.1074/jbc.273.1.600 10.1016/S0014-5793(97)01070-3 10.1111/j.1432-1033.1997.t01-1-00039.x 10.1016/0022-2836(87)90125-2 10.1111/j.1432-1033.1987.tb13476.x 10.1006/jmbi.1995.0557 10.1016/0076-6879(82)82079-X 10.1073/pnas.93.14.7369 10.1016/S0014-5793(98)01063-1 10.1074/jbc.272.7.4316 10.1016/S0021-9258(18)68844-1 10.1016/0076-6879(87)45021-0 10.1111/j.1432-1033.1992.tb17195.x 10.1016/S0021-9258(18)37604-X 10.1007/BF01923586 10.1006/jmbi.1998.2004 10.1002/j.1460-2075.1991.tb04875.x 10.1016/0076-6879(94)45024-2 10.1016/S0021-9258(18)42478-7 10.1093/emboj/17.6.1625 10.1006/jmbi.1995.0664 10.1083/jcb.131.6.1547 10.1111/j.1432-1033.1995.0681p.x 10.1016/S0021-9258(18)54445-8 10.1016/0014-5793(96)01082-4 10.1073/pnas.90.21.10404 10.1038/ki.1993.10 10.1016/0092-8674(94)90031-0 10.1017/S0033583500005783 10.1016/S0021-9258(18)98776-4 10.1006/jmbi.1994.0020 10.1016/S0021-9258(19)38948-3 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1046/j.1432-1327.1999.00127.x |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry |
EISSN | 1432-1033 |
EndPage | 926 |
ExternalDocumentID | 10_1046_j_1432_1327_1999_00127_x 10092882 FEBS127 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | -DZ -~X .55 .GA .GJ .Y3 10A 1OC 24P 29G 31~ 36B 3O- 4.4 51W 51X 52N 52O 52P 52R 52S 52T 52W 52X 53G 5GY 5HH 5LA 5RE 66C 7PT 8-1 8-4 8-5 930 A01 A03 AAEVG AAHHS AAZKR ABDBF ABEFU ABJNI ACCFJ ACFBH ACGFS ACMXC ACNCT ACXQS ADBBV ADIZJ ADZOD AEEZP AEIMD AEQDE AETEA AEUQT AFBPY AFPWT AFZJQ AI. AIWBW AJBDE ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR BAWUL BY8 C45 CAG CO8 COF CS3 D-7 D-F DIK E3Z EAD EAP EAS EAU EBB EBC EBD EBS EBX EJD EMB EMK EMOBN EST ESX EX3 F00 F01 F04 F5P G-S G8K GODZA GX1 HZI IH2 IHE IPNFZ L7B LH4 LP6 LP7 LW6 MVM O9- OBS OHT OVD P4B P4D QB0 RIG ROL SDH SUPJJ SV3 TEORI TR2 TUS UB1 VH1 WH7 WOW WQJ WRC WXI X7M XG1 Y6R YFH YSK YUY ZGI ZXP CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c4817-8ba888f92a124271334c5ad71eb9c74154f134d24e0a0596768953787dbd64743 |
IEDL.DBID | 24P |
ISSN | 0014-2956 |
IngestDate | Fri Aug 16 08:06:35 EDT 2024 Thu Sep 26 16:11:30 EDT 2024 Sat Sep 28 08:36:55 EDT 2024 Sat Aug 24 00:54:16 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4817-8ba888f92a124271334c5ad71eb9c74154f134d24e0a0596768953787dbd64743 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1432-1327.1999.00127.x |
PMID | 10092882 |
PQID | 69646918 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_69646918 crossref_primary_10_1046_j_1432_1327_1999_00127_x pubmed_primary_10092882 wiley_primary_10_1046_j_1432_1327_1999_00127_x_FEBS127 |
PublicationCentury | 1900 |
PublicationDate | February 1999 1999-Feb 1999-02-00 19990201 |
PublicationDateYYYYMMDD | 1999-02-01 |
PublicationDate_xml | – month: 02 year: 1999 text: February 1999 |
PublicationDecade | 1990 |
PublicationPlace | Oxford, UK |
PublicationPlace_xml | – name: Oxford, UK – name: England |
PublicationTitle | European journal of biochemistry |
PublicationTitleAlternate | Eur J Biochem |
PublicationYear | 1999 |
Publisher | Blackwell Science Ltd |
Publisher_xml | – name: Blackwell Science Ltd |
References | 1987; 262 1987; 145 1993; 61 1997; 272 1991; 10 1992; 208 1988; 263 1998; 435 1995; 254 1995; 131 1995; 253 1992; 11 1990; 265 1993; 3 1987b; 166 1998; 273 1987; 197 1998; 17 1996; 29 1991; 266 1994; 302 1992; 116 1988; 178 1994; 79 1992; 119 1995; 245 1995; 320 1996; 257 1998; 282 1997; 414 1993; 49 1997; 250 1992; 267 1993; 43 1996; 93 1989; 184 1993; 90 1996; 241 1995; 231 1985; 260 1998; 255 1996; 15 1995; 270 1997; 124 1994; 245 1994; 242 1993; 12 1997; 326 1991; 200 1982; 82 1994; 120 1997; 243 1995; 227 1996; 271 1996; 396 e_1_2_7_5_2 e_1_2_7_3_2 Heremans A. (e_1_2_7_27_2) 1990; 265 Noonan D.M. (e_1_2_7_18_2) 1991; 266 e_1_2_7_9_2 Narindrasorasak S. (e_1_2_7_25_2) 1991; 266 Noonan D.M. (e_1_2_7_49_2) 1988; 263 Kadoya Y. (e_1_2_7_60_2) 1997; 124 Murdoch A.D. (e_1_2_7_19_2) 1992; 267 e_1_2_7_13_2 e_1_2_7_41_2 e_1_2_7_11_2 e_1_2_7_43_2 e_1_2_7_45_2 e_1_2_7_47_2 e_1_2_7_26_2 e_1_2_7_28_2 Yurchenco P.D. (e_1_2_7_30_2) 1987; 262 Battaglia C. (e_1_2_7_7_2) 1993; 61 e_1_2_7_50_2 e_1_2_7_52_2 e_1_2_7_23_2 e_1_2_7_31_2 e_1_2_7_54_2 e_1_2_7_21_2 e_1_2_7_33_2 e_1_2_7_56_2 e_1_2_7_35_2 e_1_2_7_58_2 e_1_2_7_37_2 e_1_2_7_39_2 e_1_2_7_4_2 e_1_2_7_2_2 Ekblom P. (e_1_2_7_59_2) 1994; 120 e_1_2_7_8_2 e_1_2_7_6_2 e_1_2_7_16_2 e_1_2_7_61_2 e_1_2_7_14_2 e_1_2_7_40_2 e_1_2_7_12_2 Hassell J.R. (e_1_2_7_15_2) 1985; 260 e_1_2_7_42_2 e_1_2_7_10_2 e_1_2_7_44_2 e_1_2_7_46_2 e_1_2_7_48_2 e_1_2_7_29_2 e_1_2_7_24_2 e_1_2_7_51_2 e_1_2_7_22_2 e_1_2_7_32_2 e_1_2_7_53_2 e_1_2_7_20_2 e_1_2_7_34_2 e_1_2_7_55_2 e_1_2_7_36_2 e_1_2_7_57_2 Heremans A. (e_1_2_7_17_2) 1988; 263 e_1_2_7_38_2 |
References_xml | – volume: 273 start-page: 600 year: 1998 end-page: 605 article-title: Agrin is a high‐affinity binding protein of dystroglycan in non‐muscle tissue publication-title: J. Biol. Chem. – volume: 272 start-page: 4316 year: 1997 end-page: 4322 article-title: Identification of sites in domain I of perlecan that regulate heparan sulfate synthesis. publication-title: J. Biol. Chem. – volume: 266 start-page: 12878 year: 1991 end-page: 12883 article-title: High affinity interactions between the Alzheimer’s β‐amyloid precursor proteins and the basement membrane form of heparan sulfate proteoglycan. publication-title: J. Biol. Chem. – volume: 10 start-page: 3137 year: 1991 end-page: 3146 article-title: Recombinant nidogen consists of three globular domains and mediates binding of laminin to collagen type IV. publication-title: EMBO J. – volume: 253 start-page: 347 year: 1995 end-page: 357 article-title: The C‐terminal portion of BM‐40 (SPARC/osteonectin) is an autonomously folding and crystallisable domain that binds calcium and collagen IV. publication-title: J. Mol. Biol. – volume: 320 start-page: 84 year: 1995 end-page: 95 article-title: Differential binding of vascular cell‐derived proteoglycans (perlecan, biglycan, decorin and versican) to the beta‐amyloid protein of Alzheimer’s disease. publication-title: Arch. Biochem. Biophys. – volume: 245 start-page: 469 year: 1994 end-page: 488 article-title: Electron microscopy of extracellular matrix components. publication-title: Methods Enzymol. – volume: 12 start-page: 1879 year: 1993 end-page: 1885 article-title: A single EGF‐like motif of laminin is responsible for high affinity nidogen binding. publication-title: EMBO J. – volume: 15 start-page: 349 year: 1996 end-page: 357 article-title: Structural and cell‐adhesive properties of the three recombinant fragments derived from perlecan domain III. publication-title: Matrix Biol. – volume: 241 start-page: 827 year: 1996 end-page: 834 article-title: Expression and characterization of human perlecan domains I and II synthesized by baculovirus‐infected insect cells. publication-title: Eur. J. Biochem. – volume: 79 start-page: 1005 year: 1994 end-page: 1013 article-title: Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor‐receptor binding, mitogenesis, and angiogenesis. publication-title: Cell – volume: 260 start-page: 8098 year: 1985 end-page: 8105 article-title: Isolation of two forms of basement membrane proteoglycan. publication-title: J. Biol. Chem. – volume: 200 start-page: 529 year: 1991 end-page: 536 article-title: Recombinant expression and properties of the human calcium‐binding extracellular matrix protein BM‐40. publication-title: Eur. J. Biochem. – volume: 124 start-page: 683 year: 1997 end-page: 691 article-title: Importance of nidogen binding to laminin γ1 for branching epithelial morphogenesis of the submandibular gland. publication-title: Development – volume: 242 start-page: 309 year: 1994 end-page: 320 article-title: The immunoglobulin fold. Structural classification, sequence patterns and common core. publication-title: J. Mol. Biol. – volume: 267 start-page: 8544 year: 1992 end-page: 8557 article-title: Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG2/Perlecan). A chimeric molecule with mutiple domains homologous to the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor. publication-title: J. Biol. Chem. – volume: 166 start-page: 11 year: 1987b end-page: 19 article-title: Laminin‐nidogen complex: extraction with chelating agents and structural characterization. publication-title: Eur. J. Biochem. – volume: 15 start-page: 5154 year: 1996 end-page: 5159 article-title: Site‐directed mutagenesis and structural interpretation of the nidogen binding site of laminin γ1 chain. publication-title: EMBO J. – volume: 17 start-page: 1625 year: 1998 end-page: 1634 article-title: Crystal structure and mapping by site directed mutagenesis of the collagen‐binding epitope of an activated form of BM‐40/SPARC/osteonectin. publication-title: EMBO J. – volume: 11 start-page: 4281 year: 1992 end-page: 4290 article-title: Structure of recombinant N‐terminal globule of type VI collagen α3 chain and its binding to heparin and hyaluronan. publication-title: EMBO J. – volume: 245 start-page: 241 year: 1995 end-page: 250 article-title: Structural characterization of two variants of fibulin‐1 that differ in nidogen affinity. publication-title: J. Mol. Biol. – volume: 263 start-page: 16379 year: 1988 end-page: 16387 article-title: Identification of cDNA clones encoding different domains of the basement membrane heparan sulfate proteoglycan. publication-title: J. Biol. Chem. – volume: 184 start-page: 241 year: 1989 end-page: 248 article-title: Binding of nidogen and the laminin‐nidogen complex to basement membrane collagen type IV. publication-title: Eur. J. Biochem. – volume: 3 start-page: 846 year: 1993 end-page: 852 article-title: The immunoglobulin superfamily. publication-title: Curr. Opin. Struct. Biol. – volume: 61 start-page: 92 year: 1993 end-page: 99 article-title: Structural basis of β1 integrin‐mediated cell adhesion to a large heparan sulphate proteoglycan from basement membranes. publication-title: Eur. J. Cell Biol. – volume: 208 start-page: 359 year: 1992 end-page: 366 article-title: Basement membrane heparan sulfate proteoglycan binds to laminin by its heparan sulfate chains and to nidogen by sites in the protein core. publication-title: Eur. J. Biochem. – volume: 231 start-page: 551 year: 1995 end-page: 556 article-title: Structural properties of recombinant domain III‐3 of perlecan containing a globular domain inserted into an epidermal‐growth‐factor‐like motif. publication-title: Eur. J. Biochem. – volume: 227 start-page: 681 year: 1995 end-page: 686 article-title: Binding properties and protease stability of recombinant human nidogen. publication-title: Eur. J. Biochem. – volume: 131 start-page: 1547 year: 1995 end-page: 1560 article-title: An amino‐terminal extension is required for the secretion of chick agrin and its binding to extracellular matrix. publication-title: J. Cell Biol. – volume: 396 start-page: 127 year: 1996 end-page: 131 article-title: Structural characterization of domain II of the basement membrane proteoglycan perlecan. publication-title: FEBS Lett. – volume: 271 start-page: 9595 year: 1996 end-page: 9602 article-title: Perlecan and basement membrane‐chondroitin sulfate proteoglycan (bamacan) are two basement membrane chondroitin/dermatan sulfate proteoglycans in the Engelbreth‐Holm‐Swarm tumor matrix. publication-title: J. Biol. Chem. – volume: 90 start-page: 10404 year: 1993 end-page: 10408 article-title: Structural characterization of the complete human perlecan gene and its promoter. publication-title: Proc. Natl Acad. Sci. USA – volume: 265 start-page: 8716 year: 1990 end-page: 8724 article-title: The core protein of the matrix‐associated heparan sulfate proteoglycan binds to fibronectin. publication-title: J. Biol. Chem. – volume: 243 start-page: 115 year: 1997 end-page: 121 article-title: Characterization of recombinant perlecan domain I and its substitution by glycosaminoglycans and oligosaccharides. publication-title: Eur. J. Biochem. – volume: 262 start-page: 17668 year: 1987 end-page: 17676 article-title: Self‐assembly of a high molecular weight basement membrane heparan sulfate proteoglycan into dimers and oligomers. publication-title: J. Biol. Chem. – volume: 414 start-page: 557 year: 1997 end-page: 561 article-title: Properties of the extracellular calcium binding module of the proteoglycan testican. publication-title: FEBS Lett. – volume: 82 start-page: 472 year: 1982 end-page: 498 article-title: Antibodies to collagens and procollagens. publication-title: Methods Enzymol. – volume: 120 start-page: 2003 year: 1994 end-page: 2014 article-title: Role of mesenchymal nidogen for epithelial morphogenesis in vitro. publication-title: Development – volume: 255 start-page: 60 year: 1998 end-page: 66 article-title: Mapping of the binding of platelet‐derived growth factor to distinct domains of the basement membrane proteins BM‐40 and perlecan and distinction from the BM‐40 collagen‐binding epitope. publication-title: Eur. J. Biochem. – volume: 282 start-page: 99 year: 1998 end-page: 109 article-title: Nidogen‐2: a new basement membrane protein with diverse binding properties. publication-title: J. Mol. Biol. – volume: 326 start-page: 829 year: 1997 end-page: 836 article-title: Binding of perlecan to transthyretin in vitro. publication-title: Biochem. J. – volume: 119 start-page: 945 year: 1992 end-page: 959 article-title: Endothelial cells interact with the core protein of basement membrane perlecan through β1 and β3 integrins: an adhesion modulated by glycosaminoglycan. publication-title: J. Cell Biol. – volume: 250 start-page: 39 year: 1997 end-page: 46 article-title: The C‐terminal domain V of perlecan promotes β1 integrin‐mediated cell adhesion, binds heparin, nidogen and fibulin‐2 and can be modified by glycosaminoglycans. publication-title: Eur. J. Biochem. – volume: 263 start-page: 4731 year: 1988 end-page: 4739 article-title: Heparan sulfate proteoglycan from the extracellular matrix of human lung fibroblasts. Isolation, purification, and core protein characterization publication-title: J. Biol. Chem. – volume: 116 start-page: 559 year: 1992 end-page: 571 article-title: Human basement membrane heparan sulfate proteoglycan core protein: a 467‐KD protein containing multiple domains resembling elements of the low density lipoprotein receptor, laminin, neural cell adhesion molecules and epidermal growth factor publication-title: J. Cell Biol. – volume: 270 start-page: 404 year: 1995 end-page: 409 article-title: Recombinant domain III of perlecan promotes cell attachment through its RGDS sequence. publication-title: J. Biol. Chem. – volume: 197 start-page: 297 year: 1987 end-page: 313 article-title: Structure of low density heparan sulfate proteoglycan isolated from a mouse tumor basement membrane. publication-title: J. Mol. Biol. – volume: 93 start-page: 7369 year: 1996 end-page: 7374 article-title: Alternative splicing of agrin regulates its binding to heparin, α‐dystroglycan, and the cell surface. publication-title: Proc. Natl Acad. Sci. USA – volume: 145 start-page: 363 year: 1987 end-page: 391 article-title: Basement membranes. publication-title: Methods Enzymol. – volume: 302 start-page: 625 year: 1994 end-page: 639 article-title: The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices. publication-title: Biochem. J. – volume: 254 start-page: 892 year: 1995 end-page: 899 article-title: Binding of mouse and human fibulin‐2 to extracellular matrix ligands. publication-title: J. Mol. Biol. – volume: 271 start-page: 10079 year: 1996 end-page: 10086 article-title: The degradation of human endothelial cell‐derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin and heparanases. publication-title: J. Biol. Chem. – volume: 29 start-page: 119 year: 1996 end-page: 167 article-title: Structure and distribution of modules in extracellular proteins. publication-title: Q. Rev. Biophys. – volume: 49 start-page: 417 year: 1993 end-page: 428 article-title: Proteoglycans of basement membranes. publication-title: Experientia – volume: 17 start-page: 335 year: 1998 end-page: 343 article-title: Electron microscopic structure of agrin and mapping of its binding site in laminin‐1. publication-title: EMBO J. – volume: 266 start-page: 22939 year: 1991 end-page: 22947 article-title: The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, LDL‐receptor and N‐CAM. publication-title: J. Biol. Chem. – volume: 178 start-page: 71 year: 1988 end-page: 80 article-title: Characterization of proteolytic fragments of the laminin‐nidogen complex and their affinity in ligand binding assays. publication-title: Eur. J. Biochem. – volume: 43 start-page: 53 year: 1993 end-page: 60 article-title: Perlecan, the large low density proteoglycan of basement membranes: structure and variant forms. publication-title: Kidney Int. – volume: 257 start-page: 644 year: 1996 end-page: 657 article-title: Crystal structure of three consecutive laminin‐type epidermal growth factor‐like (LE) modules of laminin γ1 chain harboring the nidogen binding site. publication-title: J. Mol. Biol. – volume: 435 start-page: 169 year: 1998 end-page: 172 article-title: Inhibition of glycosaminoglycan modification of perlecan domain I by site‐directed mutagenesis changes protease sensitivity and laminin‐1 binding activity. publication-title: FEBS Lett. – ident: e_1_2_7_48_2 doi: 10.1002/j.1460-2075.1993.tb05836.x – volume: 260 start-page: 8098 year: 1985 ident: e_1_2_7_15_2 article-title: Isolation of two forms of basement membrane proteoglycan. publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(17)39569-8 contributor: fullname: Hassell J.R. – ident: e_1_2_7_46_2 doi: 10.1111/j.1432-1033.1988.tb14430.x – volume: 124 start-page: 683 year: 1997 ident: e_1_2_7_60_2 article-title: Importance of nidogen binding to laminin γ1 for branching epithelial morphogenesis of the submandibular gland. publication-title: Development doi: 10.1242/dev.124.3.683 contributor: fullname: Kadoya Y. – ident: e_1_2_7_13_2 doi: 10.1074/jbc.271.17.10079 – volume: 120 start-page: 2003 year: 1994 ident: e_1_2_7_59_2 article-title: Role of mesenchymal nidogen for epithelial morphogenesis in vitro. publication-title: Development doi: 10.1242/dev.120.7.2003 contributor: fullname: Ekblom P. – volume: 262 start-page: 17668 year: 1987 ident: e_1_2_7_30_2 article-title: Self‐assembly of a high molecular weight basement membrane heparan sulfate proteoglycan into dimers and oligomers. publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)45431-2 contributor: fullname: Yurchenco P.D. – ident: e_1_2_7_44_2 doi: 10.1111/j.1432-1033.1991.tb16214.x – ident: e_1_2_7_8_2 doi: 10.1093/emboj/17.2.335 – ident: e_1_2_7_28_2 doi: 10.1042/bj3260829 – ident: e_1_2_7_36_2 doi: 10.1111/j.1432-1033.1995.0551d.x – ident: e_1_2_7_31_2 doi: 10.1083/jcb.119.4.945 – ident: e_1_2_7_29_2 doi: 10.1046/j.1432-1327.1998.2550060.x – ident: e_1_2_7_58_2 doi: 10.1002/j.1460-2075.1996.tb00899.x – ident: e_1_2_7_50_2 doi: 10.1111/j.1432-1033.1989.tb15013.x – ident: e_1_2_7_33_2 doi: 10.1016/S0945-053X(96)90138-9 – ident: e_1_2_7_26_2 doi: 10.1006/abbi.1995.1345 – ident: e_1_2_7_5_2 doi: 10.1074/jbc.271.16.9595 – ident: e_1_2_7_32_2 doi: 10.1074/jbc.270.1.404 – ident: e_1_2_7_35_2 doi: 10.1111/j.1432-1033.1997.t01-1-00115.x – ident: e_1_2_7_14_2 doi: 10.1111/j.1432-1033.1996.00827.x – ident: e_1_2_7_57_2 doi: 10.1006/jmbi.1996.0191 – ident: e_1_2_7_56_2 doi: 10.1002/j.1460-2075.1992.tb05527.x – ident: e_1_2_7_3_2 doi: 10.1042/bj3020625 – ident: e_1_2_7_38_2 doi: 10.1016/0959-440X(93)90147-D – ident: e_1_2_7_20_2 doi: 10.1083/jcb.116.2.559 – ident: e_1_2_7_39_2 doi: 10.1016/S0022-2836(84)71582-8 – ident: e_1_2_7_11_2 doi: 10.1074/jbc.273.1.600 – ident: e_1_2_7_47_2 doi: 10.1016/S0014-5793(97)01070-3 – ident: e_1_2_7_10_2 doi: 10.1111/j.1432-1033.1997.t01-1-00039.x – ident: e_1_2_7_16_2 doi: 10.1016/0022-2836(87)90125-2 – ident: e_1_2_7_40_2 doi: 10.1111/j.1432-1033.1987.tb13476.x – ident: e_1_2_7_51_2 doi: 10.1006/jmbi.1995.0557 – ident: e_1_2_7_54_2 doi: 10.1016/0076-6879(82)82079-X – ident: e_1_2_7_9_2 doi: 10.1073/pnas.93.14.7369 – ident: e_1_2_7_22_2 doi: 10.1016/S0014-5793(98)01063-1 – ident: e_1_2_7_37_2 doi: 10.1074/jbc.272.7.4316 – volume: 263 start-page: 4731 year: 1988 ident: e_1_2_7_17_2 article-title: Heparan sulfate proteoglycan from the extracellular matrix of human lung fibroblasts. Isolation, purification, and core protein characterization. publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)68844-1 contributor: fullname: Heremans A. – ident: e_1_2_7_45_2 doi: 10.1016/0076-6879(87)45021-0 – ident: e_1_2_7_6_2 doi: 10.1111/j.1432-1033.1992.tb17195.x – volume: 263 start-page: 16379 year: 1988 ident: e_1_2_7_49_2 article-title: Identification of cDNA clones encoding different domains of the basement membrane heparan sulfate proteoglycan. publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)37604-X contributor: fullname: Noonan D.M. – ident: e_1_2_7_2_2 doi: 10.1007/BF01923586 – ident: e_1_2_7_23_2 doi: 10.1006/jmbi.1998.2004 – ident: e_1_2_7_41_2 doi: 10.1002/j.1460-2075.1991.tb04875.x – ident: e_1_2_7_53_2 doi: 10.1016/0076-6879(94)45024-2 – volume: 267 start-page: 8544 year: 1992 ident: e_1_2_7_19_2 article-title: Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG2/Perlecan). A chimeric molecule with mutiple domains homologous to the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor. publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)42478-7 contributor: fullname: Murdoch A.D. – ident: e_1_2_7_52_2 doi: 10.1093/emboj/17.6.1625 – ident: e_1_2_7_24_2 doi: 10.1006/jmbi.1995.0664 – ident: e_1_2_7_4_2 doi: 10.1083/jcb.131.6.1547 – ident: e_1_2_7_42_2 doi: 10.1111/j.1432-1033.1995.0681p.x – volume: 266 start-page: 22939 year: 1991 ident: e_1_2_7_18_2 article-title: The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, LDL‐receptor and N‐CAM. publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)54445-8 contributor: fullname: Noonan D.M. – ident: e_1_2_7_34_2 doi: 10.1016/0014-5793(96)01082-4 – ident: e_1_2_7_61_2 doi: 10.1073/pnas.90.21.10404 – volume: 61 start-page: 92 year: 1993 ident: e_1_2_7_7_2 article-title: Structural basis of β1 integrin‐mediated cell adhesion to a large heparan sulphate proteoglycan from basement membranes. publication-title: Eur. J. Cell Biol. contributor: fullname: Battaglia C. – ident: e_1_2_7_55_2 doi: 10.1038/ki.1993.10 – ident: e_1_2_7_12_2 doi: 10.1016/0092-8674(94)90031-0 – ident: e_1_2_7_21_2 doi: 10.1017/S0033583500005783 – volume: 266 start-page: 12878 year: 1991 ident: e_1_2_7_25_2 article-title: High affinity interactions between the Alzheimer’s β‐amyloid precursor proteins and the basement membrane form of heparan sulfate proteoglycan. publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)98776-4 contributor: fullname: Narindrasorasak S. – ident: e_1_2_7_43_2 doi: 10.1006/jmbi.1994.0020 – volume: 265 start-page: 8716 year: 1990 ident: e_1_2_7_27_2 article-title: The core protein of the matrix‐associated heparan sulfate proteoglycan binds to fibronectin. publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(19)38948-3 contributor: fullname: Heremans A. |
SSID | ssj0006967 |
Score | 1.8224823 |
Snippet | Domain IV of mouse perlecan, which consists of 14 immunoglobulin superfamily (IG) modules, was prepared from recombinant human cell culture medium in the form... |
SourceID | proquest crossref pubmed wiley |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 917 |
SubjectTerms | Animals Basement Membrane - metabolism basement membranes binding assays Biosensing Techniques Calcium-Binding Proteins - metabolism Cell Line Circular Dichroism Extracellular Matrix Proteins - metabolism Fibronectins - metabolism Heparan Sulfate Proteoglycans Heparin - metabolism Heparitin Sulfate - chemistry Heparitin Sulfate - genetics Laminin - metabolism Membrane Glycoproteins - metabolism Mice Microscopy, Electron Peptide Fragments - metabolism Peptide Fragments - ultrastructure Protein Binding proteoglycan structure Proteoglycans - chemistry Proteoglycans - genetics Radioimmunoassay recombinant production Recombinant Proteins - metabolism |
Title | Recombinant domain IV of perlecan binds to nidogens, laminin–nidogen complex, fibronectin, fibulin‐2 and heparin |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1046%2Fj.1432-1327.1999.00127.x https://www.ncbi.nlm.nih.gov/pubmed/10092882 https://search.proquest.com/docview/69646918 |
Volume | 259 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LSgMxFA1SF7oR39ZnFuLKgU4mTWeWWlrUhQha6S4kkwwWbKa0FXTXTxD8Q7_EezMzxaILcZeZYRK4J49zkpt7CTll1sKqoeKAG20DnoUiSCxLQaXEMCMzK1jmHWRvxVWP3_Sb_dL_Ce_CFPEh5htuODL8fI0DXOkiC0nDR7fFQR6xANRUC6_c-bCTUAQ-uQwsJ8YezvjdfFYWiSjiZ4Y8YCAKSq-e6oTzt5oWl6of_HORzvr1qLtO1koiSS8K5DfIknWbZOvCgYgevtEz6l07_Z75JllpV2ndtsgUBedQewcYavKhGjh6_UjzjI7s-NmCpSl8NBM6zakbmBw62OScQr_BTBKfs4_yHfW-6Pb1nGZgxdzhvOn8A7q2f87eGVXO0CeLWQ7dNul1Ow_tq6BMvRCkPMZ1SyuQxlnCFCDJUMjytKlMK7Q6SZGEAKoRN4zbhsIEPiBakmYEg99oIziwkh1Sc9D2HqFRnEWR1UIxLbgGtZU1klQz0UxiA-zG1klYWVmOiggb0p-Mc-GVScQkIiMRGemRka91clLBIcF8eMahnM1fJhJgBsEfxnWyW6D0rc5GwkBP1InwsP25MdntXN5Daf-_Px6Q1SLYAzrBHJLadPxij4DKTPWx76NfWmfniA |
link.rule.ids | 315,786,790,11589,27957,27958,46087,46511 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEB5ED3oR367PHMSTxW2aje1RxWV9IvjAW0iaFBfcVNwV9OZPEPyH_hJn0q4oehBvaUsTyJd5fMlkBmCDO4dWQ6eRsMZFoohllDmeI0tJUSNzJ3kRAmTPZOdKHN20bupyQHQXpsoP8bnhRpIR9DUJOG1Ib9fHkrWUJzxCOrVDd-5C3klsokM5RgW-SUq5OP9UyzKTVQLNWEQcWUEd1jM84vytp--26ocD-t2fDQapPQWTtSfJdivop2HE-RmY3fXIonvPbJOF2M6waT4D4_vDum6zMCDG2TMhAobZsqe7nh1es7Jg9-7hzuFUM_xo-2xQMt-1Ja6w_hbDhUOlJN5f3up3LASju6ctVuA0lp4Upw8PFNv-_vLKmfaW3Toqc-jn4Kp9cLnfieraC1EuUjJcRiM3LjKuEUpOTFbkLW13YmeynLwQhDURlgvX1FTBB1lL1kpQ-q2xUqBbMg-jHsdeBJakRZI4IzU3UhikW0Uzyw2XrSy16N64BsTDWVb3VYoNFY7GhQzUJOGKkFGEjArIqKcGrA_hUDh9dMihvSsf-wphRsYfpw1YqFD60mcz40goGiADbH8eTLUP9i6wtfTfH9dhvHN5eqJODs-Ol2GiyvxAETErMDp4eHSr6NcMzFpYrx_MC-rp |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEB5EQb2Ib9dnDuLJ4jbNxvboa_GFCD7wFpImRcFNF3cFvfkTBP-hv8SZtCuKHsRb2tIE5ktm5ksmMwDr3Dm0GjqNhDUuEkUso8zxHFlKihqZO8mLECB7Jg-vxPFN66aOf6K7MFV-iM8NN1oZQV_TAu_aYqs-lawXecIjZFPbdOUupJ3EJvqTI0I2UyJiXJx_amWZySp_ZiwijqSgjuoZnHD-1tN3U_XD__zuzgZ71J6EidqRZDsV8lMw5Pw0zOx4JNGdZ7bBQmhn2DOfhrG9QVm3GegT4eyYEADDbNnRd54dXbOyYF33cO9Q0gw_2h7rl8zf2RInWG-T4byhShLvL2_1OxZi0d3TJitQiqUnvenDA4W2v7-8cqa9ZbeOqhz6WbhqH1zuHUZ16YUoFynZLaORGhcZ14gkJyIr8pa227EzWU5OCKKaCMuFa2oq4IOkJWsluPitsVKgVzIHwx7HXgCWpEWSOCM1N1IYZFtFM8sNl60stejduAbEAymrbpVhQ4WTcSEDM0m4ImQUIaMCMuqpAWsDOBSKj844tHflY08hzEj447QB8xVKX_psZhz5RANkgO3Pg6n2we4Fthb_--MajJ7vt9Xp0dnJEoxXeR8oHmYZhvsPj24FvZq-WQ3T9QN1quob |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Recombinant+domain+IV+of+perlecan+binds+to+nidogens%2C+laminin-nidogen+complex%2C+fibronectin%2C+fibulin-2+and+heparin&rft.jtitle=European+journal+of+biochemistry&rft.au=Hopf%2C+M&rft.au=G%C3%B6hring%2C+W&rft.au=Kohfeldt%2C+E&rft.au=Yamada%2C+Y&rft.date=1999-02-01&rft.issn=0014-2956&rft.volume=259&rft.issue=3&rft.spage=917&rft.epage=925&rft_id=info:doi/10.1046%2Fj.1432-1327.1999.00127.x&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0014-2956&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0014-2956&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0014-2956&client=summon |